-
1 week ago | 
dailyindependent.com | Whitney McKnight
“Here’s what happens,” Charlie Raymond tells me over the phone. “I’ve had a lot of people in Kentucky who had sightings many years ago but they suppressed it. They didn’t tell people because they’d be ridiculed.”Raymond is the founder of the Kentucky Bigfoot Research Organization.
-
1 week ago | 
portugues.medscape.com | Whitney McKnight
O uso de Cannabis entre idosos está aumentando, de acordo com pesquisadores que usaram um banco de dados nacional dos Estados Unidos para estudar padrões recentes no uso da substância por idosos. Os resultados foram publicados on-line no periódico JAMA Internal Medicine. Após observar uma tendência de crescimento no uso de Cannabis por idosos — de 1% em 2005 para 4,2% em 2018 —, um grupo de pesquisadores liderado pelo Dr. Benjamin H.
-
3 weeks ago | 
medscape.com | Whitney McKnight
Cannabis use in older adults is up, according to researchers who used a national survey database to study emergent patterns in older adult use of the substance. Their results were published online in JAMA Internal Medicine. After noting an upward trend in seniors using cannabis — from 1.0% in 2005 to 4.2% in 2018— a group of investigators led by Benjamin H.
-
3 weeks ago | 
medscape.com | Whitney McKnight
Often citing concerns about side effects, Gen Z women (born between 1997 and 2012), increasingly are shunning evidence-based family planning and reproductive health counsel, turning instead to advice from social media influencers and fertility tracking apps — with mixed results — according to experts. Federal data published in 2020, the most recent data currently available, reported that only about 14% of women in the United States used oral contraception.
-
3 weeks ago | 
documental.substack.com | Whitney McKnight
This is a follow-up to my almost off-hand comments about DOGE last night. Because the media and global “leaders” have created a hall of mirrors that I avoid entering it most of the time. I read Carole Cadwalladr this afternoon, and realized it’s the same as it ever was. DOGE might be defunct, but no one in government ever goes away once they’ve been accommodated. Not really. Yet, again, gaslighting. DOGE was supposed to fix waste and bloat by editing the government.
-
3 weeks ago | 
documental.substack.com | Whitney McKnight
Greetings. My apologies for mistreating you by ghosting the joint. I turned off paid subs, though, so I hope that was helpful. I have been so wrapped up in running my newspaper, I’ve dropped a few balls in the juggle. I also have a second project I will tell you about toward the end of this post. My newspaper lives online, and is called The Edge. It has been a success almost right out of the gate, to my dismay, frankly.
-
1 month ago | 
medscape.com | Whitney McKnight
Whether clinicians are accurately diagnosing thyroid disease was at issue for Chinese researchers who demonstrated that adding subgroup differences according to age, sex, or race when testing for thyroid disease reduced by half the number of persons eligible for L-thyroxine, a treatment for hypothyroidism. It is the first study to examine the effect of combined age, sex, and race on the diagnosis of thyroid diseases, the authors wrote. The results were published in the Annals of Internal Medicine.
-
2 months ago | 
medscape.com | Whitney McKnight
There’s no money to study breastfeeding or provide care. There are packs of angry influencers and others on social media ready to vilify anyone who addresses it in clinical terms. Perhaps most dispiriting of all is that breastfeeding is so misunderstood in the medical community; problems encountered during breastfeeding are too often misdiagnosed and mistreated.
-
2 months ago | 
medscape.com | Whitney McKnight
The main takeaway from a recent US Preventive Services Task Force (USPSTF) update on breastfeeding interventions is that a lack of support at the primary care level, compounded by societal barriers, can interfere with a family’s desire to breastfeed their child and even make them feel badly about their circumstances, according to experts.
-
Mar 17, 2025 | 
medscape.com | Whitney McKnight
The MUC-1 vaccine tecemotide plus standard neoadjuvant systemic therapy was shown to notably improve distant relapse-free survival and overall survival rates in breast cancer patients, in a new study. "This is the first successful study of a breast cancer vaccine to date," Christian F. Singer, MD, said during an interview. Dr Singer, the lead author of the new study, presented the results during a poster session at the 2024 annual meeting of the American Society of Clinical Oncology (ASCO).
